All In Biotech

Drug Trial Radar · NCT07458984

FMT Capsules for rCDI

Fecal Microbiota (FMT) Oral Capsules in the Treatment of Recurrent Clostridioides Difficile Infection

Last checked: Nov 20, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

76

Planned (sponsor's estimate)

Start

Apr 25, 2026

Primary completion

Dec 31, 2029

Study completion Dec 31, 2030

Sponsor

Lead sponsor
Helsinki University Central HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 9, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Double blind RCT study of tretment of recurrent Clostridioides difficile infection by FMT capsules.

Conditions

  • Clostridioides Difficile Infection Recurrence
  • FMT

Interventions

  • Healthy donor stoolBiological

    Healthy donor stool given by capsules produced by the same method as in Copenhagen University Hospital

  • placebo capsuleBiological

    Copenhagen University Hvidrovre Hospital method for capsule production

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of patients with recurrence of Clostridioides difficile infection (rCDI), defined as positive fecal Clostridioides difficile nucleinic acid measurement and diarrhea after Fecal Microbiota transplantation (FMT) within 12 weeks after FMT.Time frame: The investigators evaluate the number of patietns who get rCDI within 12 weeks after FMT (Placebo or active FMT).

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Helsinki University Hospital

    Helsinki, Uusimaa, Finland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.